摘要
Abstract
Objective:To investigate the clinical effect of Shuxuening combined with Edaravone on nerve function and vascular recanalization in patients with acute cerebral infarction.Methods:A total of 90 patients with acute cerebral infarction admitted to Shouguang Hospital of Traditional Chinese Medicine from January 2021 to January 2024 were selected as the study objects and divided into a control group and a study group according to random number table method,with 45 cases in each group.The control group was treated with Edaravone,and the study group was combined with Shuxuening on the basis of the control group.The total effective rate,nerve function,self-care ability,vascular recanalization and adverse reactions of the two groups were observed and compared.Results:The total effective rate of the study group was 93.33%,which was higher than 73.33%of the control group,the difference was statistically significant(P<0.05).After treatment,the National Institutes of Health Stroke Scale score of the study group was(8.77±0.72)points,which was lower than(10.44±0.58)points of the control group,and the Activity of Daily Living scale score was(75.08±4.11)points,which was higher than(67.25±4.08)points of the control group,the differences were statistically significant(P<0.05).The vascular revascularization rate in the study group was 95.56%,which was higher than 73.33%in the control group,the difference was statistically significant(P<0.05).The incidence of dizziness,headache,edema,pruritus and decreased appetite in the study group was 20.00%,which was lower than 24.44%in the control group,but the difference was not statistically significant between the two groups(P>0.05).Conclusion:The clinical effect of Shuxuening combined with Edaravone in the treatment of acute cerebral infarction patients is accurate,which can improve nerve function,promote vascular recanalization,improve quality of life,and have good safety.关键词
急性脑梗死/舒血宁/依达拉奉/神经功能/血管再通/不良反应Key words
Acute cerebral infarction/Shuxuening/Edaravone/Neurological function/Vascular recanalization/Adverse reactions分类
医药卫生
